A new drug is hugely effective at protecting people from HIV infection and needs to be injected only twice a year.

The Centers for Disease Control and Prevention has awarded a $1.4 million grant to a University of Albany professor, Melonie ...

the International Antiviral (formerly AIDS) Society-USA (IAS-USA) has published new international guidelines for the treatment and prevention of HIV. The updated recommendations were developed by ...

The claim: New $40,000 twice yearly shot is 'AIDS cure' A Dec. 2 Instagram post ... There is not yet a price set for the drug when used for HIV prevention. "Gilead plans to file for our first ...

HIV and AIDS infections were rising ... but the modern-day treatment and prevention options really give us the tools that we need to control it.” Here’s what you need to know about HIV ...

The world may look back on 2024 as a pivotal time in the fight against AIDS ... to HIV using long-acting antiretroviral medicines. Young women in southern Africa have described new prevention ...

Hopkins said that lenacapavir was expected to be reviewed by the U.S. Food and Drug Administration in 2025, with the potential to dramatically reduce HIV infection. "This will be a critical next step ...

Phoenix is looking for artists to create a mural for a community health center downtown. Applications are being accepted from ...

"Lenacapavir does not cure AIDS. It is a powerful antiviral medication that can be used for HIV treatment in combination with other medications or for HIV prevention by itself." David D.

LONDON, Dec 17 (Reuters) - A new long-acting preventive HIV drug could reach the world ... head of supply operations at the Global Fund to Fight AIDS, Tuberculosis and Malaria.

A milestone was reached in the fight against HIV/AIDS with the development of Lenacapavir, a new injectable drug that ...

The plan states that the situation of HIV/AIDS prevention and control in China remains severe, with complex and intertwined social factors influencing its spread. The infection rate among men who ...